Cosmetic pharmacology
Open-knowledge reference entry
Cosmetic psychopharmacology, a term coined in 1990 by the psychiatrist Peter D. Kramer and popularized in his 1993 book Listening to Prozac, refers to the use of drugs to move persons from a normal psychological state to another normal state that is more desired or better socially rewarded — e.g., from melancholy towards assertiveness and confidence or from slower to quicker cognition.
The comparison is with surgery, in which the same intervention can be therapeutic (as in reparative work on burn victims) or cosmetic (as in rhinoplasty for the enhancement of beauty in conventional terms). In general, cosmetic psychopharmacology refers to the use of psychoactive medications by normal, healthy individuals for the purpose of enhancement rather than the treatment of a formal pathology. Kramer reported that with the antidepressant Prozac, occasional patients seemed "better than well," and he discussed the ethical dilemmas that might result if similar medications were offered to individuals not afflicted with psychiatric disorders. Following these case reports, much controversy arose over the veracity and ethics of the cosmetic use of actual antidepressants and other similar medications.
Opponents of cosmetic pharmacology believe that such drug usage is unethical and that the concept of cosmetic pharmacology is a manifestation of naive consumerism. Proponents, such as philosopher Arthur Caplan, state that it is an individual's (rather than the government's or physician's) right to determine whether to use a drug for cosmetic purposes.
Anjan Chatterjee, a neurologist at the University of Pennsylvania, has argued that western medicine stands on the brink of a neuro-enhancement revolution in which people will be able to improve their memory and attention through pharmacological means. Jacob M. Appel, a Brown University ethicist, has raised concerns about the possibility of employers mandating such enhancements for their workers.
See also
Performance-enhancing drugs
Cognitive liberty
Neuroenhancement
Neuroethics
Nootropics
References
Scientific articles via PubMed
Bjorklund P (April 2005).
This brief starts where responsible research should: with the source description of “Cosmetic pharmacology” as open-knowledge reference entry. Everything that follows is an evidence route, not borrowed authority.
Why this record matters
The subject matters to the general reference register because the source frames it as open-knowledge reference entry. Its deeper value depends on whether names, dates, institutions and citations support that framing.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Sep 30, 2025. The linked authority identifier is Q5174016. None of the 0 selected statements returned an explicit reference. The first chronological checks are 1990, 1993 and 2005.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The source lead contains qualifying language; that uncertainty should survive quotation, summary and reuse. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Cosmetic pharmacology”, its source revision and the description used here.
- Expand the search: follow Cosmetic pharmacology primary sources, Cosmetic pharmacology archive and Cosmetic research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Cosmetic pharmacology”?
- Which cited source is closest to the event, object or claim?
- What terminology or title could unlock a more precise catalogue search?
Search terms from this dossier
This entry incorporates text from “Cosmetic pharmacology” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.